Drawing for GENEA BIOMEDX GERI

USPTO serial 79172364

GENEA BIOMEDX GERI

Reviewed by CopyMark Law Group

Reg. 5029101Status 706Renewal
Filing date
Status date
Registration date
Aug 30, 2016
Examiner
MITTLER, ROBIN M
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with GENEA BIOMEDX GERI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric Lamb

Eric Lamb FBT Gibbons LLP111 Monument CircleSuite 4500INDIANAPOLIS, IN 46204

Goods and services

ClassDescriptionStatusFirst use
009Scientific and laboratory apparatus, instruments and equipment, namely, incubators and parts and fittings specially designed therefor used to support development of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes and being for scientific use; apparatus, instruments and equipment for clinical and medical laboratory use, namely, incubators and parts and fittings specially designed therefor used to support development of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes and being for laboratory use; laboratory equipment and supplies, namely, incubators; laboratory equipment and supplies, namely, incubators for scientific use; laboratory equipment and supplies, namely, incubators for scientific and laboratory use in the fields of reproductive science, human fertility, human reproduction and assisted conceptionACTIVE—
010Medical apparatus, instruments and equipment, namely, incubators and parts and fittings specially designed therefor used to support development of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes for in vitro fertilization or treatment of infertility and other disorders relating to fertility and human reproduction; incubators for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 28, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 28, 202671AGREGISTERED-SEC.71 ACCEPTED—
Sep 21, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 24, 2026ES71TEAS SECTION 71 RECEIVED—
Aug 30, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jul 3, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Sep 8, 2023NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 8, 202371AGREGISTERED-SEC.71 ACCEPTED—
Sep 7, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 20, 2023ES71TEAS SECTION 71 RECEIVED—
Jan 7, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 30, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 15, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 18, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 18, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 23, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 1, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 1, 2016FIMPFINAL DISPOSITION PROCESSED—
Nov 30, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 30, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 15, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 14, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 14, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 1, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 1, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 25, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 7, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 7, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 6, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 6, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 23, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 24, 2015RFNTREFUSAL PROCESSED BY IB—
Oct 8, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 8, 2015RFRRREFUSAL PROCESSED BY MPU—
Oct 7, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 6, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2015DOCKASSIGNED TO EXAMINER—
Sep 22, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 18, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 17, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance